Antimicrobial sensitisers: Gatekeepers to avoid the development of multidrug-resistant bacteria

被引:2
作者
Wang, Hanfei [1 ,2 ]
Yang, Yingying [1 ,2 ]
Wang, Simeng [1 ,2 ]
Badawy, Sara [3 ,4 ]
Ares, Irma [5 ,6 ]
Martinez, Marta [5 ,6 ]
Lopez-Torres, Bernardo [5 ,6 ]
Martinez-Larranaga, Maria-Rosa [5 ,6 ]
Wang, Xu [1 ,2 ,3 ]
Anadon, Arturo [5 ,6 ]
Martinez, Maria-Aranzazu [5 ,6 ]
机构
[1] Huazhong Agr Univ, Natl Reference Lab Vet Drug Residues HZAU, Wuhan 430070, Hubei, Peoples R China
[2] Huazhong Agr Univ, MAO Key Lab Detect Vet Drug Residues, Wuhan 430070, Hubei, Peoples R China
[3] Huazhong Agr Univ, MAO Lab Risk Assessment Qual & Safety Livestock &, Wuhan 430070, Hubei, Peoples R China
[4] Benha Univ, Fac Vet Med, Pathol Dept Anim Med, Banha, Egypt
[5] Univ Complutense Madrid UCM, Fac Vet Med, Dept Pharmacol & Toxicol, Madrid 28040, Spain
[6] Res Inst Hosp 12 De Octubre I 12, Madrid 28040, Spain
基金
中国国家自然科学基金;
关键词
Multidrug-resistant bacteria; Antibiotic adjuvant; Antimicrobial sensitizer; Indirect antibacterial; GRAM-NEGATIVE BACTERIA; 3 POSITIVE CHARGES; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; CLAVULANIC ACID; BETA-LACTAM; IN-VITRO; PEPTIDES; 4-HYDROXYBENZALDEHYDE; SUSCEPTIBILITY;
D O I
10.1016/j.jconrel.2024.03.031
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The resistance of multidrug-resistant bacteria to existing antibiotics forces the continued development of new antibiotics and antibacterial agents, but the high costs and long timeframe involved in the development of new agents renders the hope that existing antibiotics may again play a part. The "antibiotic adjuvant" is an indirect antibacterial strategy, but its vague concept has, in the past, limited the development speed of related drugs. In this review article, we put forward an accurate concept of a "non-self-antimicrobial sensitisers (NSAS)", to distinguish it from an "antibiotic adjuvant", and then discuss several scientific methods to restore bacterial sensitivity to antibiotics, and the sources and action mechanism of existing NSAS, in order to guide the development and further research of NSAS.
引用
收藏
页码:25 / 38
页数:14
相关论文
共 124 条
  • [21] Enhancing the antibacterial activity of antimicrobial peptide PMAP-37(F34-R) by cholesterol modification
    Chen, Liangliang
    Shen, Tengfei
    Liu, Yongqing
    Zhou, Jiangfei
    Shi, Shuaibing
    Wang, Yang
    Zhao, Zhanqin
    Yan, Zhiling
    Liao, Chengshui
    Wang, Chen
    [J]. BMC VETERINARY RESEARCH, 2020, 16 (01)
  • [22] Synthesis and antibacterial activity of iron-hexacyanocobaltate nanoparticles
    Ciabocco, Michela
    Cancemi, Patrizia
    Saladino, Maria Luisa
    Caponetti, Eugenio
    Alduina, Rosa
    Berrettoni, Mario
    [J]. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2018, 23 (03): : 385 - 398
  • [23] Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases
    Citorik, Robert J.
    Mimee, Mark
    Lu, Timothy K.
    [J]. NATURE BIOTECHNOLOGY, 2014, 32 (11) : 1141 - 1145
  • [24] A Common Platform for Antibiotic Dereplication and Adjuvant Discovery
    Cox, Georgina
    Sieron, Arthur
    King, Andrew M.
    De Pascale, Gianfranco
    Pawlowski, Andrew C.
    Koteva, Kalinka
    Wright, Gerard D.
    [J]. CELL CHEMICAL BIOLOGY, 2017, 24 (01): : 98 - 109
  • [25] Antimicrobial Tolerance and Metabolic Adaptations in Microbial Biofilms
    Crabbe, Aurelie
    Jensen, Peter Ostrup
    Bjarnsholt, Thomas
    Coenye, Tom
    [J]. TRENDS IN MICROBIOLOGY, 2019, 27 (10) : 850 - 863
  • [26] Antimicrobial peptides against drug resistant Mycobacterium abscessus
    da Silva, Joas L.
    Gupta, Shashank
    Olivier, Kenneth N.
    Zelazny, Adrian M.
    [J]. RESEARCH IN MICROBIOLOGY, 2020, 171 (5-6) : 211 - 214
  • [27] Dai Wei-Jing, 2016, Mol Ther Nucleic Acids, V5, pe349, DOI 10.1038/mtna.2016.58
  • [28] MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in Escherichia coli
    Daly, Seth M.
    Sturge, Carolyn R.
    Felder-Scott, Christina F.
    Geller, Bruce L.
    Greenberg, David E.
    [J]. MBIO, 2017, 8 (06):
  • [29] Streptomyces thermoviolaceus SRC3 strain as a novel source of the antibiotic adjuvant streptazolin: A statistical approach toward the optimized production
    Djinni, Ibtissem
    Djoudi, Warda
    Souagui, Samiha
    Rabia, Farida
    Rahmouni, Sihem
    Mancini, Ines
    Kecha, Mouloud
    [J]. JOURNAL OF MICROBIOLOGICAL METHODS, 2018, 148 : 161 - 168
  • [30] Copper Ions and Coordination Complexes as Novel Carbapenem Adjuvants
    Djoko, Karrera Y.
    Achard, Maud E. S.
    Phan, Minh-Duy
    Lo, Alvin W.
    Miraula, Manfredi
    Prombhul, Sasiprapa
    Hancock, Steven J.
    Peters, Kate M.
    Sidjabat, Hanna E.
    Harris, Patrick N.
    Mitic, Natasa
    Walsh, Timothy R.
    Anderson, Gregory J.
    Shafer, William M.
    Paterson, David L.
    Schenk, Gerhard
    McEwan, Alastair G.
    Schembri, Mark A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (02)